Back to All Events

Substance Misuse & Addiction Series Part 2

Waging a Counterattack on Opioids in the Workplace and at Home

April 13, 2022 7:30–8:45 a.m. Pacific • FREE REGISTRATION

The opioid crisis is waging a war across the US. More than 93,000 Americans died of overdoses in 2020. This number has doubled in the past 5 years. 70% of these were the result of opioids; 73% of the opioid overdoses are from the lethal synthetic Fentanyl. 28 states had increases of 30% or greater in opioid overdoses in 2020. According to the National Safety Council, approximately 75% of workplaces are affected by this crisis.

Construction workers and extended families are disproportionately at risk. Learn how to protect your workforce and your family from opioids through practical and proven first-exposure (dose) prevention strategies in Workers Compensation and Employee Health Benefit Programs. Learn risk assessment methods to evaluate the risk in your organizations and families. Learn innovative approaches to counter these identified exposures through risk management strategies to prevent and mitigate exposure to first doses and/or addiction during medical and surgical procedures.

This series will be presented online. Webinar login details will be sent to you after registration.

Learning Objectives:

  • Describe the risks of soft tissue injuries and surgical procedures at work, home and/or play (athletics/sports).

  • Identify the mental and physical effects of chronic pain learning alternatives to opioids and opioid-sparing protocols.

  • Assess the human and financial consequences of opioids in Work Compensation and Employee Medical Health Benefit claims.

  • Learn how Enhanced Recovery After Surgery (ERAS) protocols optimize surgical outcomes in work- and/or home-related cases.

  • Discuss recommendations, resources, and tools available to help companies and families address the risk of opioids, including practical first-exposure prevention strategies.

Co-Presenters:

Cal Beyer, CWP, Vice President; Workforce Risk and Worker Wellbeing; Holmes Murphy & Associates.

Brand Newland, PharmD, is CEO and Co-founder of Goldfinch Health based in Austin, Texas.

Previous
Previous
April 7

Free Pre-Apprenticeship Classes

Next
Next
April 15

DCL Demand - Where Do We Go From Here?